메뉴 건너뛰기
Climacteric
Volumn 14, Issue 2, 2011, Pages 195-196
Has the time for the definitive, randomized, placebo-controlled HRT trial arrived?

(2)  Panay, Nick a   Fenton, Anna a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

ESTROGEN; PROGESTERONE;
EID: 79952802731     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.561546     Document Type: Editorial
Times cited : (19)
References (9)
  • 1
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial
    • Writing Group for the Women's Health Initiative Investigators
    • Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
    • (2002) JAMA , vol.288 , pp. 321-333
  • 2
    • 68749108089 scopus 로고    scopus 로고
    • Using basic science to design a clinical trial: Baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)
    • Miller VM, Black DM, Brinton EA, et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2009;2:228-39
    • (2009) J Cardiovasc Transl Res , vol.2 , pp. 228-239
    • Miller, V.M.1    Black, D.M.2    Brinton, E.A.3
  • 3
    • 79952777514 scopus 로고    scopus 로고
    • A 'window of opportunity': The reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent
    • Oct 25. Epub ahead of print
    • Hodis HN, Mack WJ. A 'window of opportunity': the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent. Brain Res 2010 Oct 25. Epub ahead of print
    • (2010) Brain Res
    • Hodis, H.N.1    Mack, W.J.2
  • 5
    • 33947606765 scopus 로고    scopus 로고
    • Ultra-low-dose estradiol and norethisterone acetate: Effective menopausal symptom relief
    • DOI 10.1080/13697130701298107, PII 775656801
    • Panay N, Ylikorkala O, Archer DF, Rakov V, Gut R, Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric 2007;10:120-31 (Pubitemid 46482176)
    • (2007) Climacteric , vol.10 , Issue.2 , pp. 120-131
    • Panay, N.1    Ylikorkala, O.2    Archer, D.F.3    Gut, R.4    Lang, E.5
  • 6
    • 41549169669 scopus 로고    scopus 로고
    • Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer
    • Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol 2008;26: 1260-8
    • (2008) J Clin Oncol , vol.26 , pp. 1260-1268
    • Fournier, A.1    Fabre, A.2    Mesrine, S.3    Boutron-Ruault, M.C.4    Berrino, F.5    Clavel-Chapelon, F.6
  • 7
    • 33847116637 scopus 로고    scopus 로고
    • Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: The ESTHER study
    • DOI 10.1161/CIRCULATIONAHA.106.642280, PII 0000301720070220000008
    • Canonico M, Oger E, Plu-Bureau G, et al. Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007;115: 840-5 (Pubitemid 46294724)
    • (2007) Circulation , vol.115 , Issue.7 , pp. 840-845
    • Canonico, M.1    Oger, E.2    Plu-Bureau, G.3    Conard, J.4    Meyer, G.5    Levesque, H.6    Trillot, N.7    Barrellier, M.-T.8    Wahl, D.9    Emmerich, J.10    Scarabin, P.-Y.11
  • 8
    • 75149186597 scopus 로고    scopus 로고
    • Bioidentical hormones: What is all the hype about?
    • Panay N, Fenton A. Bioidentical hormones: what is all the hype about? Climacteric 2010;13:1-3
    • (2010) Climacteric , vol.13 , pp. 1-3
    • Panay, N.1    Fenton, A.2
  • 9
    • 68349129906 scopus 로고    scopus 로고
    • Relief of vasomotor symptoms with the tissueselective estrogen complex containing bazedoxifene/conjugated estrogens: A randomized, controlled trial
    • Pinkerton JV, Utian WH, Constantine GD, Olivier S, Pickar JH. Relief of vasomotor symptoms with the tissueselective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial. Menopause 2009;16: 1116-24
    • (2009) Menopause , vol.16 , pp. 1116-1124
    • Pinkerton, J.V.1    Utian, W.H.2    Constantine, G.D.3    Olivier, S.4    Pickar, J.H.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.